Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


In Brief: Selfcare

This article was originally published in The Gray Sheet

Executive Summary

Selfcare: Initial shipments of the firm's electrochemical blood glucose monitoring system to distribution partner Johnson & Johnson's LifeScan subsidiary will be delayed pending an in-house evaluation of the system by J&J, Selfcare announces Sept. 29. Selfcare, which received 510(k) clearance for the system in June, had expected to begin shipments in the third quarter ("The Gray Sheet" July 7, In Brief). Results of the J&J evaluation are due in October. "There can be no assurances that there will not be further delays" in shipments until the results are received, states Selfcare CEO Ron Zwanziger...



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts